GAN

GAN Limited

1.55 USD

Last updated Dec 9, 11:19 UTC

Yesterday HIGH

$1.57

Yesterday LOW

$1.53

52w HIGH

$2.49

52w LOW

$0.83

EPS

-0.18

PE

-8.61

Next Earnings

Mar 28, 2024

Overview News Insider Transactions Government Trades

GAN Limited stock is down -6.63% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 December’s closed higher than November.

GAN Limited operates as a supplier of enterprise software-as-a-service solutions to online casino gaming and sports betting applications in the United States, Europe, Latin America, and internationally. It offers and licenses GameSTACK, an internet gaming platform that provides turnkey technology solution for regulated real-money internet gambling, online sports betting, and virtual simulated gaming.

Stock Exchange

NASDAQ

Sector

Services

Industry

Computer Software

Headquarters

Irvine, United States Of America

Website

gan.com

Benzinga Insights

Thu Jun 29, 2023

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Benzinga Insights

Wed Jun 21, 2023

11 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights

Wed May 10, 2023

Recap: GAN Q1 Earnings
Happy Mohamed

Wed May 10, 2023

GAN Q1 EPS $0.03 Beats $(0.18) Estimate, Sales $35.13M Miss $37.66M Estimate

GAN (NASDAQ:GAN) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.18) by 116.67 percent. This is a 137.5 percent increase over losses of $(0.08) per share from the same
Benzinga Insights

Wed May 10, 2023

Earnings Scheduled For May 10, 2023

Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.
Benzinga Insights

Tue May 9, 2023

Preview: GAN's Earnings
Charles Gross

Fri Apr 14, 2023

Top Wall Street Bets Mentions For Friday April 14, 2023: SPY, JPM, NVDA, TSLA, QQQ, FRC, AAPL, AMD, GAN, SCHW
Lisa Levin

Fri Mar 31, 2023

Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.
Benzinga Newsdesk

Fri Mar 31, 2023

Northland Capital Markets Maintains Market Perform on GAN, Lowers Price Target to $2.5

Northland Capital Markets analyst Greg Gibas maintains GAN (NASDAQ:GAN) with a Market Perform and lowers the price target from $2 to $2.5.
Michael Horton

Thu Mar 30, 2023

GAN Q4 Adj. EPS $(0.24) Misses $(0.12) Estimate

GAN (NASDAQ:GAN) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.12) by 100 percent. This is a 20 percent decrease over losses of $(0.20) per share from the same period

Green Eric J, Director

Fri Nov 10, 2023

GAN Recent Insider Trades and Stock Chart

129,870 shares converted
Chang Brian P, Interim CFO

Tue Oct 31, 2023

GAN Recent Insider Trades and Stock Chart

5,070 shares converted